PLEASANTON, Calif., Sept. 22, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced the appointment of Barbara R. Paul, M.D. to its board of directors.
"We are pleased to have Dr. Paul join the Natus Board of Directors," said Robert Gunst, chairman of Natus' board of directors. "Dr. Paul's significant medical and regulatory experience will complement the expertise of our current Board members."
Dr. Paul currently sits on the board of Quorum Health Corporation, an operator and manager of 38 general acute care hospitals and outpatient services. She served as Senior Vice President & Chief Medical Officer at Community Health Systems (CHS) from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. (now Golden Living, Inc.). Dr. Paul's career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program (Centers for Medicare & Medicaid Services, CMS) for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin - Madison and earned her medical degree from Stanford University School of Medicine.
"We are excited to have Dr. Paul join the Natus board of directors," said Jim Hawkins, President and Chief Executive Officer of the Company. "Dr. Paul's background in patient care and at CMS will bring a unique perspective to our board and be invaluable as we grow."
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 [email protected]


Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



